Publication | Closed Access

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

VaccinationVaccine DevelopmentImmunologyEfficacy TrialSerotype-specific EfficacyVaccine EfficacyInfection ControlMedicineVaccine Research